Elemental IV is establishing local, ready-to-use sterile injectable manufacturing — reducing Australia's reliance on imports, and the shortages that put hospital care at risk.
Australia depends on distant supply lines for the sterile medicines its hospitals use every day. When that chain breaks — and it does, repeatedly — hospitals ration, substitute, and fall back on costly emergency imports. Many ready-to-use presentations simply aren't made here, so clinicians prepare them by hand, adding cost, delay and the risk of error at the point of care.
Elemental IV is establishing South Australian capability to manufacture finished, ready-to-administer sterile injectable products — the hospital-critical medicines Australia is most exposed on. Made here, in ready-to-use form, they shorten the supply chain, reduce manual preparation, and give hospitals a dependable domestic source.
A domestic source for products that are import-dependent and shortage-prone — closer to the hospitals that rely on them.
Ready-to-administer presentations reduce manual preparation and the medication errors that come with it.
Local sterile manufacturing that strengthens Australia's medical supply chain and reduces dependence on imports.
We're at the foundation stage — defining the facility, the product set and the regulatory pathway in line with PIC/S and TGA expectations, and building the right partnerships in equipment, research and government to do it well. We're deliberately beginning with a small set of high-need products where local, ready-to-use supply matters most.
Facility design, product selection and the regulatory pathway.
GMP-aligned sterile manufacturing of ready-to-use products.
A reliable, sovereign source of Australia's essential sterile medicines.
We'd like to hear from investors, hospital and health partners, and collaborators who want a more resilient supply of Australia's sterile medicines.
storme@elemental-iv.com